- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ABT-869
Total 4642 results
-
AbbVieCompleted
-
AbbVieCompletedChronic Hepatitis C | Hepatitis C Virus | HCV | Direct-Acting Antiviral Agent (DAA)-Experienced
-
The Miriam HospitalUnknownEating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia Nervosa Restricting TypeUnited States
-
AbbVieCompletedChronic Hepatitis C | Hepatitis C Virus | Compensated Cirrhosis
-
AbbottCompleted
-
AbbVieActive, not recruitingHepatitis C Virus (HCV)United States, Australia, Austria, Canada, France, Germany, Italy, Spain
-
AbbVie (prior sponsor, Abbott)CompletedCognitive Deficits in SchizophreniaUnited States
-
AbbVie (prior sponsor, Abbott)CompletedChronic Hepatitis C Infection
-
AbbVieCompletedErosive Hand Osteoarthritis
-
AbbottCompleted
-
Hutchison Medipharma LimitedCompleted
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedImprovement of Abdomen AppearanceBulgaria
-
TakedaRecruitingNarcolepsy Type 1 | Narcolepsy Type 2Spain, Germany, United States, Italy, Netherlands, Japan, France, Norway, Australia, Finland, Switzerland, Sweden
-
BTL Industries Ltd.CompletedImprovement of Abdomen AppearanceBulgaria
-
Auspex Pharmaceuticals, Inc.CompletedTOURETTE SYNDROMEUnited States
-
BTL Industries Ltd.Completed
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
AbbVie (prior sponsor, Abbott)Completed
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
AbbottCompletedHealthyUnited States
-
AbbottCompleted
-
AbbottCompleted
-
AbbVieCompletedA Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 InfectionChronic Hepatitis C | Hepatitis C Virus | HCV
-
Linnaeus UniversityKronoberg County Council; Capio GroupCompletedQuality of Life | Stress | Insomnia | Psychological Distress | Depression, Anxiety | Activities, Daily LivingSweden
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
HutchmedRecruitingRelapsed/Refractory LymphomaChina
-
Kainos Medicine Inc.ParexelRecruitingMultiple System AtrophyKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
BTL Industries Ltd.UnknownImprovement of Abdomen AppearanceBulgaria
-
Merck Sharp & Dohme LLCTerminated
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Canada, Netherlands, Germany
-
AbbVie (prior sponsor, Abbott)TerminatedAlzheimer's DiseaseUnited States, Poland, Russian Federation, South Africa, Ukraine, United Kingdom
-
AbbVieTerminatedSchizophreniaUnited States, Russian Federation, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedPrimary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and OvarianNetherlands
-
AbbVieTerminatedMultiple SclerosisUnited Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedAdvanced Solid TumorsUnited States, Australia
-
AbbVieCompletedRelative BioavailabilityUnited Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedHepatitis C Virus InfectionUnited States
-
AbbVie (prior sponsor, Abbott)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
AbbottTerminatedAlzheimer's DiseaseUnited States
-
AbbottTerminatedA Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's DiseaseAlzheimer's DiseaseUnited States
-
AbbVieCompletedHepatitis C Virus Infection | Chronic Hepatitis C | Compensated Cirrhosis
-
TakedaCompletedNarcolepsy Type 1Spain, Japan, France, Germany, United States, Norway, Netherlands, Finland, Switzerland, Australia, Italy, Sweden
-
Carmot Therapeutics, Inc.Active, not recruitingObesity | Type2 DiabetesUnited States, Mexico
-
Vertex Pharmaceuticals IncorporatedCompletedAlpha1-Antitrypsin DeficiencyUnited States, Germany, Canada, Ireland, Sweden, United Kingdom
-
BTL Industries Ltd.CompletedMuscle ToneUnited States
-
Janssen Research & Development, LLCWithdrawn